NOW: $MRNA priced @ non-deployment valuation either because of #COVID19 partial success defending from the virus or if virus dies out. Even in worse case scenario proving success of #moderna_tx #mRNAplatform alone is probably worth $20B at current pipeline state. $Mrk $ibb $jnj https://t.co/qrPhqFdpvt